Alderley Edge, United Kingdom

Ian Cooper

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Redx Pharma Limited. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian Cooper. Retrieved from https://idiyas.com/inventor/ian-cooper-z9g6gwvs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ian Cooper - Innovator in Antibacterial Compounds

Introduction

Ian Cooper is a notable inventor based in Alderley Edge, GB. He has made significant contributions to the field of antibacterial drug compounds. His work focuses on developing innovative solutions to combat bacterial infections.

Latest Patents

Ian Cooper holds a patent for "Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds." This invention relates to antibacterial drug compounds containing a bicyclic core, typically a bicycle in which one of the rings is an oxazolidinone. It also encompasses pharmaceutical formulations of these antibacterial drug compounds and their applications in treating bacterial infections.

Career Highlights

Ian Cooper is associated with Redx Pharma Limited, where he contributes his expertise in the development of pharmaceutical innovations. His work has been instrumental in advancing the understanding and treatment of bacterial infections.

Collaborations

Ian collaborates with talented professionals such as Amanda Lyons and David Orr, enhancing the research and development efforts at Redx Pharma Limited.

Conclusion

Ian Cooper's innovative work in antibacterial compounds showcases his commitment to improving healthcare solutions. His contributions are vital in the ongoing battle against bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…